Toward failure analyses in systems biology

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 2, Issue 5, 2010, Pages 507-517

  Bhattacharya, Sanjoy K ^a   Gomes, James ^b   Cebulla, Colleen M ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOENGINEERING; BIOLOGICAL MODEL; COMPARATIVE STUDY; EQUIPMENT; HUMAN; NONLINEAR SYSTEM; REVIEW; STATISTICAL MODEL; SYSTEMS BIOLOGY;

ANIMALS; BIOENGINEERING; EQUIPMENT FAILURE ANALYSIS; HUMANS; LINEAR MODELS; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; SYSTEMS BIOLOGY;

EID: 79952115583     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.83     Document Type: Article

References (62)

1. Ullman DG. Mechanical Design Failure Analysis. New York: McGraw-Hill Companies; 1996.
2. Shipley RJ, Becker WT. ASM Handbook Volume 11: Failure Analysis and Prevention. Materials Park, OH: A S M International; 2002.
3. van Gend C, Snoep JL. Systems biology model databases and resources. Essays Biochem 2008, 45:223-236.
4. Aksenovich TI, Ginzburg E. Planning of samples for linkage analysis. Incomplete penetrance. Genetika 1993, 29:1741-1749.
5. Whittemore AS, Keller JB, Ward MJ. Family data determine all parameters in Mendelian incomplete penetrance models. Ann Hum Genet 1991, 55(Pt 2):175-177.
6. Majumder PP, et al. Relative risks of diseases in the presence of incomplete penetrance and sporadics. Stat Med 1983, 2:13-24.
7. Zhao XM, et al. Protein function prediction with highthroughput data. Amino Acids 2008, 35:517-530.
8. Fox A, Taylor D, Slonim OK. High throughput interaction data reveals degree conservation of hub proteins. Pac Symp Biocomput 2009, 391-402.
9. Singleton WT. Man-machine Systems. London: Penguin; 1974.
10. Rouse WB, Boff KR. System Design: Behavioral Perspectives on Designers, Tools, and Organizations. North-Holland, Amsterdam; 1987.
11. Cedersund G, Roll J. Systems biology: model based evaluation and comparison of potential explanations for given biological data. FEBS J 2009, 276:903-922.
12. Wilkinson DJ. Stochastic modelling for quantitative description of heterogeneous biological systems. Nat Rev Genet 2009, 10:122-133.
13. Salazar-Ciudad I. Evolution in biological and nonbiological systems under different mechanisms of generation and inheritance. Theory Biosci 2008, 127:343-358.
14. Lee AD, Oh YS. Unusual delayed presentation of a nail gun injury through the skull base. Laryngoscope 2007, 117:977-980.
15. Litvack ZN, et al. Self-inflicted nail-gun injury with 12 cranial penetrations and associated cerebral trauma. Case report and review of the literature. J Neurosurg 2006, 104:828-834.
16. Shields SR. Managing eye disease in primary care. Part 3. When to refer for ophthalmologic care. Postgrad Med 2000, 108:99-106.
17. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Pediatr Ophthalmol Strabismus 1999, 36:8-18; quiz 35-16.
18. Lund JS. Specificity and non-specificity of synaptic connections within mammalian visual cortex. J Neurocytol 2002, 31:203-209.
19. Schefler AC, et al. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology 2007, 114:162-169.
20. Kitano H. Introductions to systems biology. Tanpakushitsu Kakusan Koso 2003, 48:789-793.
21. Burnie D, Wilson DE. Animal: The Definitive Visual Guide to the World'sWildlife. New York: DK Publishing Inc.; 2005.
22. Gosling LM, Baker SJ. Coypu (Myocastor coypus) potential longevity. J Zool 1981, 197:285-312.
23. Bhattacharya SK. Retinal deimination in aging and disease. IUBMB Life 2009, 61:504-509.
24. Yokoyama S, et al. Cortical activation in the processing of passive sentences in L1 and L2: an fMRI study. Neuroimage 2006, 30:570-579.
25. Park DC, Jeong TK. Complex-bilinear recurrent neural network for equalization of a digital satellite channel. IEEE Trans Neural Netw 2002, 13:711-725.
26. Mukhopadhyay AK, et al. The fdxA ferredoxin gene can down-regulate frxA nitroreductase gene expression and is essential in many strains of Helicobacter pylori. J Bacteriol 2003, 185:2927-2935.
27. Kim SK, et al. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor. J Mol Graph Model 2006, 25:562-577.
28. Kim DH, et al. Scale-free trees: the skeletons of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2004, 70(4 Pt 2):046126.
29. Kim DH, et al. Universality class of the fiber bundle model on complex networks. Phys Rev Lett 2005, 94:025501.
30. Jeong JW, et al. A mathematical model for examining growth and sporulation processes of Bacillus subtilis. Biotechnol Bioeng 1990, 35:160-184.
31. Jeong H, et al. The large-scale organization of metabolic networks. Nature 2000, 407:651-654.
32. Goh KI, et al. Classification of scale-free networks. Proc Natl Acad Sci U S A 2002, 99:12583-12588.
33. Albert R, et al. Error and attack tolerance of complex networks. Nature 2000, 406:378-382.
34. Haken, H. Advanced Synergetics: Instability Hierarchies of Self-organizing Systems andDevices.Michigan: Springer-Verlag; 1983.
35. Yeger-Lotem E, et al. Network motifs in integrated cellular networks of transcription-regulation and proteinprotein interaction. Proc Natl Acad Sci U S A 2004, 101:5934-5939.
36. Shen-Orr SS, et al. Network motifs in the transcriptional regulation network of Escherichia coli. Nat Genet 2002, 31:64-68.
37. Kashtan N, et al. Topological generalizations of network motifs. Phys Rev E Stat Nonlin Soft Matter Phys 2004, 70(3 Pt 1):031909.
38. Ravasz E, et al. Hierarchical organization ofmodularity in metabolic networks. Science 2002, 297:1551-1555.
39. Milo R, et al. Network motifs: simple building blocks of complex networks. Science 2002, 298:824-827.
40. Ostroverkhov GE, et al. Comparative studies on the distrubition of albucid following its intra-arterial infusion and isolation perfusion of isolated pelvic organs under experimental conditions. Vopr Onkol 1965, 11:62-67.
41. Folkman J, et al. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966, 164:491-502.
42. Horikawa M, et al. An experimental study of hyperthermochemotherapy without oxygenation by isolated liver perfusion. Nippon Geka Gakkai Zasshi 1994, 95:512-520.
43. Horikawa, M, et al. Simple method of hyperthermochemo-hypoxic isolated liver perfusion for hepatic metastases. World J Surg 1994, 18:845-850; discussion 851.
44. Barker WC, et al. Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs. Eur J Nucl Med 1995, 22:1242-1248.
45. Kobayashi M, et al. Intraoperative local infusion chemotherapy (ILIC) for gastric cancer. Gan To Kagaku Ryoho 1998, 25:1281-1283.
46. Thorleifsson G, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007, 317:1397-1400.
47. Scott S, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 2008, 9:4-15.
48. Sethuraman, V, Sun, Q. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials. Pharm Stat 2008, 8:113-124.
49. Menashe I, et al. PGA: power calculator for casecontrol genetic association analyses. BMC Genet 2008, 9:36.
50. Case LD, Ambrosius WT. Power and sample size. Methods Mol Biol 2007, 404:377-408.
51. Teo YY. Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling and population structure. Curr Opin Lipidol 2008, 19:133-143.
52. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr Opin Ophthalmol 2008, 19:95-101.
53. Wu X, et al. Development of an accelerated GVF semiautomatic contouring algorithm for radiotherapy treatment planning. Comput Biol Med 2009, 39:650-656.
54. Simon E, et al. PET lesion segmentation using automated iso-intensity contouring in head and neck cancer. Technol Cancer Res Treat 2009, 8:249-255.
55. Ersoy I, et al. Cell Segmentation Using Hessian-Based Detection and Contour Evolution with Directional Derivatives. Proc Int Conf Image Proc 2008, 2008:1804-1807.
56. Chao M, et al. Automated contour mapping with a regional deformable model. Int J Radiat Oncol Biol Phys 2008, 70:599-608.
57. Kitano H. Biological robustness in complex hostpathogen systems. Prog Drug Res 2007, 64:241-263.
58. Frezzotti R, et al. Adult-onset primary glaucoma and molecular genetics: a review. Eur J Ophthalmol 2004, 14:220-225.
59. Ince PG, et al. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998, 24:104-117.
60. Cozzolino M, et al. Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. Antioxid Redox Signal 2008, 10: 405-443.
61. Charlton-Menys V, Durrington PN. Human cholesterol metabolism and therapeutic molecules. Exp Physiol 2008, 93:27-42.
62. Benjamin A, et al. Proteomics of the nucleus ovoidalis and field L brain regions of zebra finch. J Proteome Res 2008, 7:2121-2132.